Drug Profile
RG 7795
Alternative Names: ANA 773; RG7795Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Anadys Pharmaceuticals
- Developer Anadys Pharmaceuticals; Roche
- Class Antineoplastics; Antivirals; Small molecules
- Mechanism of Action Immunostimulants; Toll-like receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B; Hepatitis C; Solid tumours
Most Recent Events
- 01 Jul 2015 Phase-II clinical trials in Hepatitis B in Switzerland (PO)
- 02 Feb 2012 Phase-I clinical trials in Hepatitis C in Netherlands (PO)
- 02 Feb 2012 Anadys Pharmaceuticals terminates a phase IIa trial in Hepatitis C in Netherlands (ANA773-602; EudraCT2011-000728-14)